Total Payments
$11,195
2024 Payments
$3,537
Companies
31
Transactions
445
Medicare Patients
2,413
Medicare Billing
$132,274
Payment Breakdown by Category
Food & Beverage$10,674 (95.3%)
Education$520.91 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,674 | 438 | 95.3% |
| Education | $520.91 | 7 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,155 | 95 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,551 | 50 | $0 (2024) |
| GENZYME CORPORATION | $1,265 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $745.47 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $667.41 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $640.85 | 22 | $0 (2024) |
| Lilly USA, LLC | $610.03 | 27 | $0 (2024) |
| Amgen Inc. | $474.22 | 17 | $0 (2024) |
| PFIZER INC. | $375.59 | 19 | $0 (2024) |
| Incyte Corporation | $368.24 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,537 | 136 | ABBVIE INC. ($477.82) |
| 2023 | $3,542 | 144 | GENZYME CORPORATION ($522.95) |
| 2022 | $3,291 | 137 | ABBVIE INC. ($1,037) |
| 2021 | $825.94 | 28 | SUN PHARMACEUTICAL INDUSTRIES INC. ($182.68) |
All Payment Transactions
445 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 11/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.31 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.07 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 639 | 1,117 | $103,618 | $31,422 |
| 2022 | 12 | 759 | 1,367 | $129,841 | $43,025 |
| 2021 | 10 | 544 | 898 | $89,932 | $34,247 |
| 2020 | 10 | 471 | 754 | $71,206 | $23,580 |
Total Patients
2,413
Total Services
4,136
Medicare Billing
$132,274
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 161 | $22,753 | $7,205 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 106 | $18,802 | $6,464 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 77 | $15,469 | $4,506 | 29.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 90 | 103 | $16,620 | $4,493 | 27.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 112 | 151 | $16,219 | $4,020 | 24.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 434 | $5,181 | $1,645 | 31.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 41 | $3,329 | $1,216 | 36.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 13 | 16 | $2,080 | $745.60 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,604 | $586.48 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,562 | $540.73 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 207 | $28,064 | $10,510 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 103 | $19,078 | $7,547 | 39.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 89 | 113 | $20,220 | $7,105 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 135 | 188 | $19,807 | $5,424 | 27.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 88 | 104 | $16,674 | $5,189 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 93 | 511 | $10,659 | $2,099 | 19.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 13 | 19 | $5,931 | $1,986 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 23 | 29 | $2,418 | $943.99 | 39.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 12 | 12 | $2,358 | $926.31 | 39.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 22 | $1,783 | $744.18 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $2,723 | $518.27 | 19.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 43 | $126.72 | $31.99 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 165 | $19,287 | $8,298 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 96 | $16,318 | $7,658 | 46.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 56 | 71 | $12,268 | $4,772 | 38.9% |
About Ginger Atkinson, PA-C
Ginger Atkinson, PA-C is a Medical healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982945762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ginger Atkinson, PA-C has received a total of $11,195 in payments from pharmaceutical and medical device companies, with $3,537 received in 2024. These payments were reported across 445 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,674).
As a Medicare-enrolled provider, Atkinson has provided services to 2,413 Medicare beneficiaries, totaling 4,136 services with total Medicare billing of $132,274. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Raleigh, NC
- Active Since 03/04/2013
- Last Updated 03/04/2013
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1982945762
Products in Payments
- DUPIXENT (Biological) $1,837
- RINVOQ (Biological) $1,018
- SKYRIZI (Biological) $969.95
- ILUMYA (Biological) $842.09
- Sotyktu (Drug) $642.56
- TREMFYA (Drug) $569.91
- TALTZ (Drug) $469.43
- OPZELURA (Drug) $368.24
- ADBRY (Biological) $344.07
- Otezla (Drug) $305.31
- Bimzelx (Biological) $251.73
- Winlevi (Drug) $240.98
- Klisyri (Drug) $172.08
- Enbrel (Biological) $168.91
- HUMIRA (Biological) $167.78
- EUCRISA (Drug) $152.99
- VTAMA (Drug) $135.30
- COSENTYX (Biological) $133.02
- Ilumya (Biological) $120.88
- CIBINQO (Drug) $119.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Raleigh
Abigail Terkeltoub, Pa-C, PA-C
Medical — Payments: $12,406
Medical $12,406
Mrs. Kelsie Cato, Pa-C, PA-C
Medical — Payments: $11,205
Medical $11,205
Tyler Cassidy, Pa-C, PA-C
Medical — Payments: $10,417
Medical $10,417
Mrs. Lauren Wright, Pac, PAC
Medical — Payments: $9,247
Medical $9,247
Jessica Hedrick, Pa-C, PA-C
Medical — Payments: $5,609
Medical $5,609
Komal Patel, Pa-C, PA-C
Medical — Payments: $5,411
Medical $5,411